Allegheny Health Network to pause distribution of Johnson & Johnson vaccine as it undergoes national review period

The recommendation comes after six women in the U.S., aged between 18 and 48, experienced a rare blood clotting disorder 6 to 13 days after receiving the Johnson & Johnson vaccine, which to date has been administered to nearly 7 million people nationwide.